Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
Titel:
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
Auteur:
Coles, Alasdair J Fox, Edward Vladic, Anton Gazda, Suzanne K Brinar, Vesna Selmaj, Krzysztof W Bass, Ann Doan-Do Wynn, Daniel R Margolin, David H Lake, Stephen L Moran, Susan Palmer, Jeffrey Smith, M Shelton Compston, D Alastair S